Key result
Inherited FVL and FII thrombophilia mutations link to recurrent pregnancy loss in Lebanese women.
Why the study?
Recurrent pregnancy loss often has unknown etiology, and the correlation between inherited thrombophilia mutations and RPL in Lebanese women was unclear.
Are inherited thrombophilia mutations (FVL G1691A, FII G20210A, MTHFR C677T) associated with recurrent pregnancy loss in Lebanese women?
Case-Control (n=220)
Are inherited thrombophilia mutations (FVL G1691A, FII G20210A, MTHFR C677T) associated with recurrent pregnancy loss in Lebanese women?
Inherited thrombophilia mutations (FVL G1691A and FII G20210A) are significantly associated with recurrent pregnancy loss in Lebanese women, supporting the consideration of thrombophilia screening in this population.
Supports association of FVL/FII mutations with recurrent pregnancy loss in Lebanese women; leaves open whether screening improves outcomes.
Recurrent pregnancy loss (RPL) complication is a challenge of reproductive medicine due to its often unknown etiology. A case-control study was carried out between June 2019 and April 2020 to examine the correlation between RPL and inherited thrombophilia (IT), namely mutations in factor V Leiden (FVL G1691A), prothrombin (FII G20210A), and methylenetetrahydrofolate reductase (MTHFR C677T). A total of 120 Lebanese women with RPL was studied and compared, for the frequency of these mutations, to 100 healthy reproductive Lebanese women. The association between the zygosity status of the three tested mutations, the existence of more than one prothrombotic single nucleotide polymorphisms (SNPs), and the increased risk of RPL were examined using Chi-square or two-tailed fisher exact test, and the student t test. The predictive factors of RPL were analyzed using a multiple logistic regression model. P<0.05 was considered to be statistically significant. Our results showed statistically significant higher frequencies of FVL G1691A and FII G20210A mutations among the cases with RPL compared to the control group. Thus, RPL is associated with FVL G1691A and FII G20210A mutations. These mutations seem to increase the risk of RPL in the Lebanese women. Therefore, we suggest thrombophilia screening and adequate genetic counseling for women with RPL and at high-risk to plan for primary prevention, avoiding thromboembolic or obstetric accidents, and reducing the associated morbidity and mortality among Lebanese women.
No takes yet. Share an insight, caveat, or question.
Khalife et al. (2022) conducted a case-control in Recurrent pregnancy loss (n=220). Inherited thrombophilia mutations (FVL G1691A, FII G20210A, MTHFR C677T) vs. Healthy reproductive Lebanese women was evaluated on Recurrent pregnancy loss. Inherited thrombophilia mutations, specifically FVL G1691A and FII G20210A, were found at significantly higher frequencies in Lebanese women with recurrent pregnancy loss compared to healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: